Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
VYNE
Stock Latest News
Company Announcements
VYNE Therapeutics Reports Q2 2025 Financials and Updates
13d ago
VYNE
Premium
Ratings
VYNE Therapeutics: Hold Rating Amid Mixed Clinical Outcomes and Financial Sustainability
13d ago
VYNE
Premium
Company Announcements
VYNE Therapeutics Directors Resign Amid Financial Updates
13d ago
8K
VYNE
Premium
The Fly
VYNE Therapeutics reports Q2 EPS (13c) vs (22c) last year
13d ago
VYNE
Premium
Pre-Earnings
VYNE Earnings this Week: How Will it Perform?
21d ago
VYNE
Premium
Market News
Watch Out! Analysts Have Recently Downgraded These Stocks
25d ago
AMD
NEO
Premium
Market News
Why Is VYNE Therapeutics Stock (VYNE) Down 70% Today?
28d ago
VYNE
Premium
The Fly
VYNE Therapeutics downgraded to Neutral from Buy at BTIG
28d ago
VYNE
Premium
Ratings
VYNE Therapeutics: Buy Rating Supported by Promising VYN202 Prospects Amidst Challenges
28d ago
VYNE
Premium
Market News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
28d ago
MO
QS
Premium
The Fly
VYNE Therapeutics downgraded at H.C. Wainwright after vitiligo trial miss
28d ago
VYNE
Premium
The Fly
VYNE Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
28d ago
VYNE
Premium
Company Announcements
VYNE Therapeutics Ends Phase 2b Trial for Repibresib
28d ago
8K
VYNE
Premium
The Fly
VYNE says Phase 2B trial with repibresib gel did not meet primary endpoint
28d ago
VYNE
Premium
Ratings
Promising Developments in VYNE Therapeutics’ Repibresib Gel for Nonsegmental Vitiligo Drive Buy Rating
1M ago
VYNE
Premium
Ratings
Promising Potential of VYNE Therapeutics’ Repibresib Gel in Phase IIb Study
2M ago
VYNE
Premium
Ratings
Promising Outlook for VYNE Therapeutics: Buy Rating Backed by Repibresib’s Potential in Vitiligo Treatment
2M ago
VYNE
Premium
Ratings
VYNE Therapeutics’ VYN202: Regulatory Milestones and Promising Clinical Data Drive Buy Rating
2M ago
VYNE
Premium
The Fly
H.C. Wainwright ‘encouraged’ by VYNE Therapeutics VYN202 update
2M ago
VYNE
Premium
Ratings
Optimistic Outlook for VYNE Therapeutics Amid Promising VYN202 Program Developments
2M ago
VYNE
Premium
The Fly
VYNE Therapeutics provides program update on VYN202 following clinical hold
2M ago
VYNE
Premium
Company Announcements
VYNE Therapeutics Reports Q1 2025 Financial Results
4M ago
VYNE
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
